The computed tomography devices market in Sweden is driven by a publicly funded healthcare system that prioritizes equitable access, technological advancement, and high clinical standards. As the primary healthcare provider, the government plays a central role in shaping market dynamics through strategic investments in diagnostic modernization and innovation. The country’s healthcare strategy places strong emphasis on early detection and preventive care, particularly in managing chronic diseases such as cancer and cardiovascular conditions. These clinical priorities, combined with a steadily aging population, are fueling sustained demand for advanced imaging solutions. Sweden is also positioning itself at the forefront of precision medicine, which relies heavily on high-resolution imaging for accurate diagnosis, staging, and treatment planning. In April 2025, the government allocated US$8.53 million to support Genomic Medicine Sweden (GMS), a national initiative aimed at integrating precision medicine into cancer care and other specialties. This funding will enhance diagnostic capabilities across the country, with CT imaging playing a critical role in the delivery of personalized treatment pathways. The Swedish CT devices market is further characterized by a strong commitment to research-driven innovation and the rapid adoption of next-generation technologies. With robust public investment, a growing clinical need for advanced diagnostics, and a national focus on personalized healthcare, Sweden is well-positioned for continued growth and leadership in the European CT imaging landscape.